Will Ozempic / semaglutide be FDA-approved for Alzheimer's before 2030?
30
2.5kṀ13532030
58%
chance
1D
1W
1M
ALL
Semaglutide (brand names: Ozempic, Rybelsus, and Wegovy) is an antidiabetic and anti-obesity drug. Its developer, Novo Nordisk, has three ongoing phase 3 trials run across the world of semaglutide for Alzheimer’s disease:
NCT04777396: 1,840 participants, started in 2021, results expected in 2026,
NCT05891496: 24 participants, started in 2023, results expected in 2025,
NCT04777409: 1,840 participants, started in 2021, results expected in 2026.
Will semaglutide be approved by the Food and Drug Administration (FDA) for Alzheimer's (or any kind of cognitive impairment) before January 1st, 2030?
Approval can be for the treatment (whether symptomatic or disease-modifying) or prevention of the targeted disease.
This question is managed and resolved by Manifold.
Get
1,000 to start trading!
1,000Sort by:
Related questions
Related questions
Will Matt Kaeberlein start taking semaglutide/ozempic by 2030?
41% chance
Will Ozempic be FDA approved for use in type 1 diabetes patients by end of 2024?
7% chance
FDA issues statement/update on Ozempic NAION risk by March 31, 2025
24% chance
Will Ozempic be ranked within the top three prescribed drugs for diabetes by June 30, 2024?
2% chance
Will the Ozempic shortage be resolved on December 31st, 2025 according to the FDA?
58% chance
Will 10 million Americans be on semaglutide (or yet-to-be-approved equally good or superior alternatives) by the end of 2030?
78% chance
Ozempic approval is revoked or withdrawn before 2031
6% chance
Will semaglutide be taken off FDA's drug shortage list in 2025?
65% chance
Will the FDA approve Viagra as a treatment for Alzheimer's before 2030?
19% chance
How many OECD countries will have court ordered semaglutide drugs (e.g., Ozempic) by the end of 2030